AYTU 8-K 2026-09-22
AYTU BIOPHARMA, INC (AYTU) 8-K dated 2026-09-22 — accession 0001437749-26-030900.
AYTU BIOPHARMA, INC (AYTU) is a drug manufacturers - specialty & generic company listed on US.
AYTU: SECURITIES AND EXCHANGE COMMISSION
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported AYTU revenue for 2026-06-30 was $57.6M. Net income was -$14.3M. Revenue was down 13.3% from 2025-06-30 to 2026-06-30. AYTU currently screens at market cap $24.1M.
Not investment advice. The AYTU SEC hub lists recent forms. The stock page is the research view.